Compare Novavax Inc (NVAX) vs S&P500 ETF (SPY) Price & Performance

Novavax IncTrade

S&P500 ETFTrade

Price performance (Past 24H)

Key statistics

Novavax Inc vs S&P500 ETF — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while S&P500 ETF trades at $748.09. The key difference: S&P500 ETF is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.

	NVAX	SPY
Market Cap	$1.30B	—
Sector	Health	—
52-Week High	$11.19	$759.55
52-Week Low	$6.22	$621.75
Enterprise Value	$800.50M	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVAX

View details →

SPY

Vanguard's VEA ETF offers low-cost developed market exposure beyond the U.S., balancing diversification and risk.24/7 Wall Street · 6 hours agoNeutral John Hancock Financial Opportunities Fund offers 6.5% growing dividend, beating S&P 500 and financial ETFs.Forbes · 13 hours agoBullish XLK ETF hides high concentration risk in top tech stocks despite low fees.24/7 Wall Street · 1 day agoNeutral View details →

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

About S&P500 ETF

The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.